Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any age, whether male or female, may be considered
- People who have been diagnosed with, or are suspected to have, a type of thyroid cancer called medullary thyroid carcinoma (MTC) — confirmed through a biopsy, elevated blood markers alongside a thyroid nodule, or a family history suggesting a hereditary condition (such as MEN2 syndrome)
- People with certain other confirmed cancers (such as some neuroendocrine tumors, or stomach or ovarian cancers) that test positive for a specific protein called CCK-2R (confirm with trial site)
- People who are expected to live for at least 12 weeks at the time of joining
- People who are willing to use effective birth control during the study, if this applies to them
- People who are willing to sign a consent form and attend follow-up appointments as required
Who may not be able to join:
- People with serious liver or kidney problems, as shown by certain abnormal blood test results (confirm with trial site for specific values)
- People who are currently pregnant, breastfeeding, or planning to become pregnant during the study
- People who are unable to lie still during a PET/CT scan — for example, due to severe claustrophobia
- People with other health conditions that the trial doctor believes could make participation unsafe (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yaping LUO, Peking Union Medical College Hospital
Phone: 86-010-69154716
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
diagnostic performance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.